In India, people familiar with the development said the company is in
discussions with Dr Reddy's Laboratories, Cipla, Jubilant
Lifesciences, and Strides Pharmaceuticals for granting them voluntary
licences for manufacturing the drug.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/gilead-looks-to-make-remdesivir-available-globally/articleshow/75542257.cms
No comments:
Post a Comment